Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Peripheral arterial disease.

Wilbert S Aronow1

  • 1Department of Medicine, New York Medical College, Valhalla, NY, USA.

Geriatrics
|January 17, 2007
PubMed
Summary
This summary is machine-generated.

Peripheral arterial disease (PAD) in seniors presents varied symptoms and increases mortality risk. Effective management includes treating comorbidities, lifestyle changes like smoking cessation, and specific medications such as statins and antiplatelet drugs.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Treatment of Hypertension in Patients With Coronary Artery Disease: A Scientific Statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension.

Journal of the American College of Cardiology·2015
Same author

Meta-analysis of risk of stroke and thrombo-embolism with rivaroxaban versus vitamin K antagonists in ablation and cardioversion of atrial fibrillation.

International journal of cardiology·2015
Same author

Antiarrhythmic properties of ranolazine: A review of the current evidence.

International journal of cardiology·2015
Same author

Treatment of hypertension in patients with coronary artery disease: a scientific statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension.

Hypertension (Dallas, Tex. : 1979)·2015
Same author

Treatment of hypertension in patients with coronary artery disease: a scientific statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension.

Circulation·2015
Same author

Lipids, blood pressure and kidney update 2014.

Pharmacological research·2015

Area of Science:

  • Geriatric Medicine
  • Vascular Medicine
  • Cardiovascular Disease

Background:

  • Peripheral arterial disease (PAD) in the elderly manifests asymptomatically, as intermittent claudication, or critical limb ischemia.
  • PAD significantly elevates the risk of all-cause mortality, cardiovascular mortality, and coronary artery disease (CAD) mortality.

Purpose of the Study:

  • To outline the clinical presentations, associated risks, and management strategies for peripheral arterial disease in the elderly population.

Main Methods:

  • Review of current medical literature and clinical guidelines for PAD management in elderly patients.
  • Analysis of pharmacological interventions including statins, antiplatelet agents, ACE inhibitors, and beta-blockers.
  • Evaluation of non-pharmacological approaches such as exercise rehabilitation and surgical interventions.

Related Experiment Videos

Main Results:

  • Treatment of comorbidities like hypertension, diabetes, dyslipidemia, and hypothyroidism is crucial.
  • Smoking cessation is paramount for PAD patients.
  • Statins improve exercise duration and reduce intermittent claudication incidence; antiplatelet drugs are recommended for all PAD patients.
  • Exercise rehabilitation and cilostazol enhance exercise capacity.
  • Chelation therapy lacks evidence and should be avoided.

Conclusions:

  • Comprehensive management of PAD in the elderly involves addressing risk factors, utilizing evidence-based medications, and considering revascularization or amputation when necessary.
  • Early diagnosis and appropriate treatment can mitigate the severe health consequences associated with PAD.